Trusted News Discovery Since 2008
{{/content}}
Gilead to Charge $3,120 Per Patient for Typical Covid-19 Treatment
Video Credit: Wochit News
Published on June 30, 2020 - Duration: 00:35s
Gilead to Charge $3,120 Per Patient for Typical Covid-19 Treatment
Gilead is the pharmaceutical company behind a drug that’s been approved for COVID emergencies.
The FDA officially announced the medicine could be used in treating COVID-19 patients.
Gilead has now announced the drug will cost $3,120 per typical treatment course for insured individuals.
Research has indicated the drug could cut the recovery time for hospitalized COVID-19 patients.
It could shorten satsy by several days, reports Gizmodo.
You are here
Related videos from verified sources
Gilead's Covid-19 Drug Remdesivir To Cost $2,340-$3,120 Per Patient 00:45
Video credit: Geo Beats - Published on June 29, 2020